Peter H. van der Meide

7.7k total citations · 1 hit paper
143 papers, 6.6k citations indexed

About

Peter H. van der Meide is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter H. van der Meide has authored 143 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Immunology, 28 papers in Molecular Biology and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter H. van der Meide's work include T-cell and B-cell Immunology (33 papers), Immune Response and Inflammation (27 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Peter H. van der Meide is often cited by papers focused on T-cell and B-cell Immunology (33 papers), Immune Response and Inflammation (27 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Peter H. van der Meide collaborates with scholars based in Netherlands, Sweden and Germany. Peter H. van der Meide's co-authors include Huub Schellekens, R. Dijkema, A.C. Arnberg, Hugh O. McDevitt, Chaim O. Jacob, Hans Link, Martin A. Dubbeld, Tomas Olsson, D S Finbloom and Miodrag Belosevic and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter H. van der Meide

143 papers receiving 6.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The hepatitis delta (δ) virus possesses a circular RNA

1986 566 citations Peter H. van der Meide, Huub Schellekens et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter H. van der Meide Netherlands	44	3.0k	1.6k	897	758	647	143	6.6k
Rick A. Wetsel United States	51	5.3k 1.8×	1.8k 1.2×	863 1.0×	564 0.7×	819 1.3×	126	8.9k
John J. Hooks United States	43	1.9k 0.7×	1.6k 1.0×	968 1.1×	535 0.7×	295 0.5×	118	5.7k
Thomas Leist United States	39	2.1k 0.7×	790 0.5×	656 0.7×	860 1.1×	526 0.8×	124	4.9k
Birgit Ledermann Switzerland	36	3.8k 1.3×	3.5k 2.3×	1.1k 1.3×	921 1.2×	462 0.7×	43	9.6k
Mátyás Sándor United States	42	2.5k 0.9×	1.2k 0.8×	896 1.0×	514 0.7×	927 1.4×	163	5.3k
Jörg Köhl Germany	59	6.4k 2.2×	2.4k 1.5×	1.2k 1.3×	441 0.6×	497 0.8×	197	10.8k
Heinrich Körner Australia	47	4.2k 1.4×	1.7k 1.1×	1.2k 1.3×	1.3k 1.7×	496 0.8×	128	7.8k
Peter N. Monk United Kingdom	44	2.6k 0.9×	2.1k 1.3×	990 1.1×	481 0.6×	518 0.8×	127	6.2k
Claudia Kemper United States	48	5.2k 1.7×	1.5k 1.0×	970 1.1×	540 0.7×	461 0.7×	136	7.9k
Ehud Lavi United States	46	1.7k 0.6×	1.1k 0.7×	1.2k 1.4×	660 0.9×	1.1k 1.7×	154	6.8k

Countries citing papers authored by Peter H. van der Meide

Since Specialization

Citations

This map shows the geographic impact of Peter H. van der Meide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. van der Meide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. van der Meide more than expected).

Fields of papers citing papers by Peter H. van der Meide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. van der Meide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. van der Meide. The network helps show where Peter H. van der Meide may publish in the future.

Co-authorship network of co-authors of Peter H. van der Meide

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. van der Meide. A scholar is included among the top collaborators of Peter H. van der Meide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. van der Meide. Peter H. van der Meide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Veldhuis, Wouter B., Sarah Floris, Peter H. van der Meide, et al.. (2003). Interferon-Beta Blocks Infiltration of Inflammatory Cells and Reduces Infarct Volume after Ischemic Stroke in the Rat. Journal of Cerebral Blood Flow & Metabolism. 23(9). 1029–1039. 111 indexed citations

Floris, Sarah, Sigrid R. Ruuls, Anne Wierinckx, et al.. (2002). Interferon-β directly influences monocyte infiltration into the central nervous system. Journal of Neuroimmunology. 127(1-2). 69–79. 149 indexed citations

Huang, Y-M, Peter H. van der Meide, Michael Levi, et al.. (1999). Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats. Clinical & Experimental Immunology. 118(1). 115–121. 26 indexed citations

Örn, Anders, et al.. (1998). IFN‐γ Is Required to Induce Experimental Autoimmune Myasthenia Gravis. Annals of the New York Academy of Sciences. 841(1). 576–579. 8 indexed citations

Bakhiet, Moiz, Tomas Olsson, Jama Mhlanga, et al.. (1996). Human and rodent interferon‐γ as a growth factor for Trypanosoma brucei. European Journal of Immunology. 26(6). 1359–1364. 46 indexed citations

Rongen, H.A.H., et al.. (1995). Biotinylated and streptavidinylated liposomes as labels in cytokine immunoassays. Analytica Chimica Acta. 306(2-3). 333–341. 11 indexed citations

Yazdanbakhsh, Maria, Erliyani Sartono, Yvonne C. M. Kruize, et al.. (1993). Elevated levels of T cell activation antigen CD27 and increased interleukin‐4 production in human lymphatic filariasis. European Journal of Immunology. 23(12). 3312–3317. 43 indexed citations

Holmdahl, Rikard, et al.. (1992). In Vivo Treatment with Interferon-Gamma during Early Pregnancy in Mice Induces Strong Expression of Major Histocompatibility Complex Class I and II Molecules in Uterus and Decidua But not in Extra-Embryonic Tissues1. Biology of Reproduction. 46(6). 1176–1186. 33 indexed citations

Moorselaar, R. Jeroen A. van, et al.. (1992). Inhibition of Rat Bladder Tumor (Rbt323) Growth by Tumor Necrosis Factor Alpha and Interferon-Gamma in Vivo. The Journal of Urology. 148(2 Part 1). 458–462. 5 indexed citations

10.

IJzermans, Jan N.M., E Bouwman, A. Bijma, et al.. (1990). Immunomodulation by Recombinant Rat Interferon-γ In Vivo. Journal of Interferon Research. 10(2). 203–211. 4 indexed citations

11.

Meide, Peter H. van der, et al.. (1990). A Sensitive Two-Site Enzyme Immunoassay for the Detection of Rat Interferon-γ in Biological Fluids. Journal of Interferon Research. 10(2). 183–189. 13 indexed citations

12.

Keller, Robert, Ruth Keist, Thomas Leist, & Peter H. van der Meide. (1990). Resistance to a non‐immunogenic tumor, induced by Corynebacterium parvum or Listeria monocytogenes, is abrogated by anti‐interferonγ. International Journal of Cancer. 46(4). 687–690. 9 indexed citations

13.

Belosevic, Miodrag, et al.. (1989). Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.. The Journal of Immunology. 143(1). 266–274. 335 indexed citations

14.

Steiniger, Birte, Peter H. van der Meide, P. Falk, & Jürgen Klempnauer. (1988). Induction of Class II MHC Antigen Expression in Rat Organs after Systemic Application of Recombinant Gamma Interferon. Advances in experimental medicine and biology. 237. 795–799. 6 indexed citations

15.

Keller, R., Peter Joller, Ruth Keist, Hans Binz, & Peter H. van der Meide. (1988). Modulation of Major Histocompatibility Complex (MHC) Expression by Interferons and Microbial Agents. Scandinavian Journal of Immunology. 28(1). 113–121. 22 indexed citations

16.

Cantell, K, Huub Schellekens, L. Pyhälä, et al.. (1986). Pharmacokinetic Studies with Human and Rat Interferons-γ in Different Species. Journal of Interferon Research. 6(6). 671–675. 13 indexed citations

17.

Leszczyński, Dariusz, Berne Ferry, Huub Schellekens, Peter H. van der Meide, & P Häyry. (1986). Antagonistic effects of gamma interferon and steroids on tissue antigenicity.. The Journal of Experimental Medicine. 164(5). 1470–1477. 20 indexed citations

18.

Schellekens, Huub, A. de Reus, & Peter H. van der Meide. (1984). The Chimpanzee as a Model to Test the Side Effects of Human Interferons. Journal of Medical Primatology. 13(5). 235–245. 10 indexed citations

19.

Bosch, L., et al.. (1983). The Elongation Factor EF-Tu and Its Two Encoding Genes. Progress in nucleic acid research and molecular biology. 30. 91–126. 78 indexed citations

20.

Westbroek, Peter, et al.. (1979). Fossil macromolecules from cephalopod shells: characterization, immunological response and diagenesis. Paleobiology. 5(2). 151–167. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact